nodes	percent_of_prediction	percent_of_DWPC	metapath
Tyloxapol—LPL—dermis—melanoma	0.201	0.489	CbGeAlD
Tyloxapol—LPL—blood vessel—melanoma	0.0567	0.138	CbGeAlD
Tyloxapol—LPL—neck—melanoma	0.0405	0.0985	CbGeAlD
Tyloxapol—LPL—eye—melanoma	0.0302	0.0733	CbGeAlD
Tyloxapol—LPL—retina—melanoma	0.0299	0.0726	CbGeAlD
Tyloxapol—LPL—mammalian vulva—melanoma	0.0239	0.0581	CbGeAlD
Tyloxapol—LPL—head—melanoma	0.0171	0.0416	CbGeAlD
Tyloxapol—LPL—lymph node—melanoma	0.012	0.0291	CbGeAlD
Tyloxapol—LPL—Disease—HS3ST5—melanoma	0.00217	0.00369	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—DCC—melanoma	0.00216	0.00368	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ACER3—melanoma	0.00214	0.00364	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—MAPK3—melanoma	0.00201	0.00341	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—RAC2—melanoma	0.00196	0.00333	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—UGT2B10—melanoma	0.00196	0.00332	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.00193	0.00328	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—MAPK1—melanoma	0.00191	0.00325	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—CDH2—melanoma	0.00187	0.00318	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—TNF—melanoma	0.00186	0.00316	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—PIK3CA—melanoma	0.00185	0.00314	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—TNF—melanoma	0.00182	0.00309	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HS3ST5—melanoma	0.00182	0.00309	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MYO7A—melanoma	0.00179	0.00304	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—DRAP1—melanoma	0.00179	0.00304	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—PAX6—melanoma	0.00165	0.0028	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—CTNNB1—melanoma	0.00162	0.00275	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—TP53—melanoma	0.0016	0.00273	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—CDKN1A—melanoma	0.00158	0.00269	CbGpPWpGaD
Tyloxapol—LPL—Disease—TRRAP—melanoma	0.00155	0.00263	CbGpPWpGaD
Tyloxapol—LPL—Disease—CUL3—melanoma	0.00155	0.00263	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TAS2R60—melanoma	0.00152	0.00258	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—AKT1—melanoma	0.00151	0.00256	CbGpPWpGaD
Tyloxapol—LPL—Disease—AKR1B10—melanoma	0.00151	0.00256	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.00146	0.00249	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—STAT3—melanoma	0.00141	0.0024	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PLCB4—melanoma	0.00138	0.00234	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—FASN—melanoma	0.00135	0.0023	CbGpPWpGaD
Tyloxapol—LPL—Disease—LUM—melanoma	0.00134	0.00228	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—ITGAV—melanoma	0.00133	0.00226	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—AKT3—melanoma	0.00133	0.00226	CbGpPWpGaD
Tyloxapol—LPL—Disease—HPSE—melanoma	0.00132	0.00224	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SLC6A11—melanoma	0.0013	0.0022	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIP4K2A—melanoma	0.0013	0.0022	CbGpPWpGaD
Tyloxapol—LPL—Disease—CUBN—melanoma	0.00129	0.00219	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—MTAP—melanoma	0.00126	0.00214	CbGpPWpGaD
Tyloxapol—LPL—Disease—CSPG4—melanoma	0.00125	0.00212	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.00123	0.00209	CbGpPWpGaD
Tyloxapol—LPL—Disease—RPS3—melanoma	0.00123	0.00209	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—TNF—melanoma	0.00122	0.00208	CbGpPWpGaD
Tyloxapol—LPL—Disease—SKI—melanoma	0.00121	0.00205	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—ITGB1—melanoma	0.00121	0.00205	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CXCL1—melanoma	0.00115	0.00196	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PLCB4—melanoma	0.00115	0.00196	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—LUM—melanoma	0.00112	0.00191	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PHGDH—melanoma	0.00112	0.00191	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HPSE—melanoma	0.0011	0.00187	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CUL3—melanoma	0.00108	0.00184	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TRRAP—melanoma	0.00108	0.00184	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CUBN—melanoma	0.00108	0.00184	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AKR1B10—melanoma	0.00105	0.00179	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—ITGB3—melanoma	0.00105	0.00178	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SDHD—melanoma	0.00104	0.00178	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CSPG4—melanoma	0.00104	0.00178	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—BSG—melanoma	0.00104	0.00178	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MAP2K2—melanoma	0.00102	0.00174	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GPAM—melanoma	0.00101	0.00172	CbGpPWpGaD
Tyloxapol—LPL—Disease—HDAC6—melanoma	0.000997	0.00169	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—IL6—melanoma	0.000986	0.00168	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—F2RL1—melanoma	0.00098	0.00167	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—RAC1—melanoma	0.000969	0.00165	CbGpPWpGaD
Tyloxapol—LPL—Disease—NPPA—melanoma	0.000945	0.00161	CbGpPWpGaD
Tyloxapol—LPL—Disease—VCAN—melanoma	0.000923	0.00157	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GRM3—melanoma	0.000921	0.00157	CbGpPWpGaD
Tyloxapol—LPL—Disease—WNT5A—melanoma	0.000915	0.00156	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—KDR—melanoma	0.000889	0.00151	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KISS1—melanoma	0.000873	0.00148	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MET—melanoma	0.00087	0.00148	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—CDK4—melanoma	0.00087	0.00148	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PLA2G6—melanoma	0.00086	0.00146	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SKI—melanoma	0.000846	0.00144	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CXCR1—melanoma	0.000846	0.00144	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—NOTCH1—melanoma	0.000837	0.00142	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MC1R—melanoma	0.000833	0.00142	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GRM1—melanoma	0.000799	0.00136	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCR7—melanoma	0.000799	0.00136	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—PPARG—melanoma	0.00079	0.00134	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SUFU—melanoma	0.000778	0.00132	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—VCAN—melanoma	0.000773	0.00131	CbGpPWpGaD
Tyloxapol—LPL—Disease—GAB2—melanoma	0.000735	0.00125	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	0.000731	0.00124	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RHOB—melanoma	0.000727	0.00124	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—BCL2L11—melanoma	0.000727	0.00124	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MMP2—melanoma	0.000726	0.00123	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MAP2K1—melanoma	0.000725	0.00123	CbGpPWpGaD
Tyloxapol—LPL—Disease—FASN—melanoma	0.000719	0.00122	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PPARG—melanoma	0.000706	0.0012	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HDAC6—melanoma	0.000698	0.00119	CbGpPWpGaD
Tyloxapol—LPL—Disease—FOXO4—melanoma	0.000691	0.00117	CbGpPWpGaD
Tyloxapol—LPL—Disease—CXCR4—melanoma	0.000691	0.00117	CbGpPWpGaD
Tyloxapol—LPL—Disease—HDAC2—melanoma	0.000691	0.00117	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—FGF2—melanoma	0.000689	0.00117	CbGpPWpGaD
Tyloxapol—LPL—Disease—CD44—melanoma	0.000683	0.00116	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CXCR2—melanoma	0.000662	0.00112	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP17A1—melanoma	0.000652	0.00111	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RAC2—melanoma	0.000651	0.00111	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	0.000643	0.00109	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—VEGFC—melanoma	0.000641	0.00109	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—WNT5A—melanoma	0.000641	0.00109	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—ERBB2—melanoma	0.000636	0.00108	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—ALB—melanoma	0.000635	0.00108	CbGpPWpGaD
Tyloxapol—LPL—Disease—AKT3—melanoma	0.000631	0.00107	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GNA11—melanoma	0.000616	0.00105	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—FASN—melanoma	0.000602	0.00102	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SLC5A5—melanoma	0.000593	0.00101	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GNAQ—melanoma	0.000572	0.000973	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CD44—melanoma	0.000572	0.000973	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—F2R—melanoma	0.000563	0.000957	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	0.00056	0.000952	CbGpPWpGaD
Tyloxapol—LPL—Disease—ERBB4—melanoma	0.000557	0.000947	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—CTNNB1—melanoma	0.000556	0.000946	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PTGS2—melanoma	0.000555	0.000944	CbGpPWpGaD
Tyloxapol—LPL—Disease—CDKN2B—melanoma	0.000552	0.000939	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP1B1—melanoma	0.000549	0.000933	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MMP9—melanoma	0.000545	0.000927	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EDNRB—melanoma	0.000545	0.000926	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—NFKB1—melanoma	0.00054	0.000917	CbGpPWpGaD
Tyloxapol—LPL—Disease—CD86—melanoma	0.000534	0.000908	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTK2B—melanoma	0.000529	0.000899	CbGpPWpGaD
Tyloxapol—LPL—Disease—FGF1—melanoma	0.000518	0.00088	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GNA11—melanoma	0.000515	0.000875	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GAB2—melanoma	0.000515	0.000875	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FLT1—melanoma	0.000512	0.000871	CbGpPWpGaD
Tyloxapol—LPL—Disease—PDGFRA—melanoma	0.000502	0.000852	CbGpPWpGaD
Tyloxapol—LPL—Disease—PRKCA—melanoma	0.000497	0.000844	CbGpPWpGaD
Tyloxapol—LPL—Disease—ERCC2—melanoma	0.000492	0.000837	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—VEGFA—melanoma	0.00049	0.000832	CbGpPWpGaD
Tyloxapol—LPL—Disease—MAP2K2—melanoma	0.000485	0.000825	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—STAT3—melanoma	0.000485	0.000824	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PTEN—melanoma	0.000484	0.000823	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HDAC2—melanoma	0.000484	0.000823	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CXCR4—melanoma	0.000484	0.000823	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FOXO4—melanoma	0.000484	0.000823	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—NRAS—melanoma	0.000484	0.000822	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GNAQ—melanoma	0.000479	0.000813	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MAPK3—melanoma	0.000463	0.000787	CbGpPWpGaD
Tyloxapol—LPL—Disease—TERT—melanoma	0.000462	0.000785	CbGpPWpGaD
Tyloxapol—LPL—Disease—HLA-A—melanoma	0.000462	0.000785	CbGpPWpGaD
Tyloxapol—LPL—Disease—RAC1—melanoma	0.00046	0.000782	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ABCB1—melanoma	0.000452	0.000768	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SYK—melanoma	0.00045	0.000765	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ITGAV—melanoma	0.000442	0.000751	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AKT3—melanoma	0.000442	0.000751	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NGFR—melanoma	0.000442	0.000751	CbGpPWpGaD
Tyloxapol—LPL—Disease—HIF1A—melanoma	0.000441	0.00075	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MAPK1—melanoma	0.000441	0.000749	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—EGFR—melanoma	0.000441	0.000749	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—TNF—melanoma	0.00042	0.000713	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—KRAS—melanoma	0.000416	0.000708	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PRKCA—melanoma	0.000416	0.000707	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ERCC2—melanoma	0.000412	0.000701	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SOCS1—melanoma	0.000409	0.000695	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—S100B—melanoma	0.000408	0.000693	CbGpPWpGaD
Tyloxapol—LPL—Disease—NOS2—melanoma	0.000402	0.000683	CbGpPWpGaD
Tyloxapol—LPL—Disease—NOTCH1—melanoma	0.000398	0.000676	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ERBB4—melanoma	0.00039	0.000663	CbGpPWpGaD
Tyloxapol—LPL—Disease—CD80—melanoma	0.00039	0.000662	CbGpPWpGaD
Tyloxapol—LPL—Disease—APC—melanoma	0.000389	0.000661	CbGpPWpGaD
Tyloxapol—LPL—Disease—KIT—melanoma	0.000389	0.000661	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CDKN2B—melanoma	0.000387	0.000657	CbGpPWpGaD
Tyloxapol—LPL—Disease—EGF—melanoma	0.000384	0.000653	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CD86—melanoma	0.000374	0.000636	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EDN1—melanoma	0.000371	0.000631	CbGpPWpGaD
Tyloxapol—LPL—Disease—BRAF—melanoma	0.000366	0.000621	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CSF2—melanoma	0.000363	0.000616	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FGF1—melanoma	0.000363	0.000616	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—E2F1—melanoma	0.000355	0.000603	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—HRAS—melanoma	0.000354	0.000601	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PDGFRA—melanoma	0.000351	0.000597	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ITGB3—melanoma	0.000348	0.000591	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PRKCA—melanoma	0.000348	0.000591	CbGpPWpGaD
Tyloxapol—LPL—Disease—MAP2K1—melanoma	0.000344	0.000585	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3CD—melanoma	0.000342	0.000581	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	0.000342	0.000581	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SPP1—melanoma	0.000341	0.00058	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MAP2K2—melanoma	0.00034	0.000578	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—IL6—melanoma	0.000339	0.000576	CbGpPWpGaD
Tyloxapol—LPL—Disease—FGF2—melanoma	0.000327	0.000556	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CG—melanoma	0.000326	0.000554	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TERT—melanoma	0.000323	0.000549	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RAC1—melanoma	0.000322	0.000548	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PPARG—melanoma	0.000314	0.000534	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—AKT1—melanoma	0.000312	0.000531	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HIF1A—melanoma	0.000309	0.000525	CbGpPWpGaD
Tyloxapol—LPL—Disease—MDM2—melanoma	0.000306	0.000521	CbGpPWpGaD
Tyloxapol—LPL—Disease—ERBB2—melanoma	0.000302	0.000513	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3CB—melanoma	0.000298	0.000506	CbGpPWpGaD
Tyloxapol—LPL—Disease—CD4—melanoma	0.000297	0.000506	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KDR—melanoma	0.000296	0.000502	CbGpPWpGaD
Tyloxapol—LPL—Disease—PTGS2—melanoma	0.000295	0.000502	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CD—melanoma	0.000286	0.000487	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FN1—melanoma	0.000285	0.000484	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ALB—melanoma	0.000283	0.00048	CbGpPWpGaD
Tyloxapol—LPL—Disease—CDKN1B—melanoma	0.00028	0.000475	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NOTCH1—melanoma	0.000278	0.000473	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CD80—melanoma	0.000273	0.000464	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—APC—melanoma	0.000272	0.000463	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CG—melanoma	0.000272	0.000463	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KIT—melanoma	0.000272	0.000463	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EGF—melanoma	0.000269	0.000458	CbGpPWpGaD
Tyloxapol—LPL—Disease—CTNNB1—melanoma	0.000264	0.000449	CbGpPWpGaD
Tyloxapol—LPL—Disease—CDKN1A—melanoma	0.000258	0.000439	CbGpPWpGaD
Tyloxapol—LPL—Disease—PTEN—melanoma	0.000258	0.000438	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—BRAF—melanoma	0.000256	0.000435	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CB—melanoma	0.00025	0.000424	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IGF1—melanoma	0.000249	0.000424	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTGS2—melanoma	0.000247	0.00042	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MAP2K1—melanoma	0.000241	0.00041	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CD—melanoma	0.000239	0.000407	CbGpPWpGaD
Tyloxapol—LPL—Disease—STAT3—melanoma	0.00023	0.000391	CbGpPWpGaD
Tyloxapol—LPL—Disease—NRAS—melanoma	0.00023	0.00039	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FGF2—melanoma	0.000229	0.00039	CbGpPWpGaD
Tyloxapol—LPL—Disease—MAPK3—melanoma	0.00022	0.000374	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTEN—melanoma	0.000216	0.000367	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MDM2—melanoma	0.000214	0.000365	CbGpPWpGaD
Tyloxapol—LPL—Disease—MYC—melanoma	0.000214	0.000364	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ERBB2—melanoma	0.000211	0.000359	CbGpPWpGaD
Tyloxapol—LPL—Disease—MAPK1—melanoma	0.000209	0.000356	CbGpPWpGaD
Tyloxapol—LPL—Disease—EGFR—melanoma	0.000209	0.000356	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CB—melanoma	0.000209	0.000355	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CXCL8—melanoma	0.000201	0.000341	CbGpPWpGaD
Tyloxapol—LPL—Disease—KRAS—melanoma	0.000198	0.000336	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CDKN1B—melanoma	0.000196	0.000333	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CASP3—melanoma	0.000192	0.000326	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IL2—melanoma	0.000192	0.000326	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCND1—melanoma	0.000187	0.000318	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CTNNB1—melanoma	0.000185	0.000314	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3CA—melanoma	0.000182	0.000309	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MMP9—melanoma	0.000181	0.000308	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CDKN1A—melanoma	0.000181	0.000307	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTEN—melanoma	0.00018	0.000306	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NFKB1—melanoma	0.000179	0.000305	CbGpPWpGaD
Tyloxapol—LPL—Disease—HRAS—melanoma	0.000168	0.000286	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—VEGFA—melanoma	0.000163	0.000277	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—STAT3—melanoma	0.000161	0.000274	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NRAS—melanoma	0.000161	0.000273	CbGpPWpGaD
Tyloxapol—LPL—Disease—IL6—melanoma	0.000161	0.000273	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MAPK3—melanoma	0.000154	0.000262	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CA—melanoma	0.000152	0.000259	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MYC—melanoma	0.00015	0.000255	CbGpPWpGaD
Tyloxapol—LPL—Disease—AKT1—melanoma	0.000148	0.000252	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MAPK1—melanoma	0.000147	0.000249	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EGFR—melanoma	0.000147	0.000249	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KRAS—melanoma	0.000138	0.000235	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CA—melanoma	0.000127	0.000216	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—AKT1—melanoma	0.000124	0.000211	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TP53—melanoma	0.000123	0.000209	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HRAS—melanoma	0.000118	0.0002	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IL6—melanoma	0.000113	0.000191	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AKT1—melanoma	0.000104	0.000177	CbGpPWpGaD
